Sweden Reverse-Switches Diclofenac Over Cardio Fears
Executive Summary
Oral diclofenac will no longer be available without a prescription in Sweden after the national drug regulator judged that the potential adverse event risks were too high to justify continued OTC supply. Products from GSK and Mylan will be affected by the decision.
You may also be interested in...
Diclofenac Reverse-Switched In Norway As Risks Outweigh Benefits
Norway becomes the latest country to reverse-switch diclofenac in response to a 2018 study linking low doses of the drug to cardiovascular adverse events.
Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer
Major Europe-based consumer health players Reckitt, Sanofi, Haleon and Bayer feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q1 2024 results over the coming weeks.
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.